Xponance’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,811
Closed -$4.2M 1293
2023
Q3
$4.2M Buy
19,811
+108
+0.5% +$21.6K 0.06% 281
2023
Q2
$3.79M Buy
19,703
+1,122
+6% +$223K 0.05% 310
2023
Q1
$3.76M Buy
18,581
+53
+0.3% +$8.5K 0.06% 304
2022
Q4
$2.38M Buy
18,528
+2,427
+15% +$313K 0.04% 400
2022
Q3
$2.2M Buy
16,101
+162
+1% +$26.4K 0.04% 368
2022
Q2
$2.82M Buy
15,939
+2,074
+15% +$299K 0.06% 297
2022
Q1
$2M Buy
13,865
+153
+1% +$20.7K 0.03% 374
2021
Q4
$2.12M Buy
13,712
+97
+0.7% +$16.2K 0.03% 370
2021
Q3
$2.31M Sell
13,615
-596
-4% -$92.8K 0.04% 323
2021
Q2
$2.24M Buy
14,211
+987
+7% +$147K 0.04% 342
2021
Q1
$1.84M Buy
13,224
+48
+0.4% +$7.73K 0.04% 331
2020
Q4
$2.31M Buy
13,176
+624
+5% +$116K 0.05% 289
2020
Q3
$2.46M Sell
12,552
-49
-0.4% -$8.2K 0.06% 243
2020
Q2
$2.14M Buy
+12,601
New +$1.88M 0.06% 258

Other funds holding SGEN

Xponance's SGEN Position: Q4 2023 in Review

Xponance sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 19,811 shares — an estimated $4.2M sold.

Xponance first reported a position in SGEN in Q2 2020 and held it in 14 quarters. The position peaked at $4.2M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Xponance reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Xponance sold 19,811 Seagen Inc. Common Stock shares in Q4 2023, an estimated $4.2M.
  • Xponance first reported a position in Seagen Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Xponance's Seagen Inc. Common Stock position peaked at $4.2M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Xponance's 13F filing for Q4 2023, filed 31 Jan 2024.